Education
About Us
Working with TipRanks
Follow Us
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
RESEARCH TOOLSreports
Comparison Results
Shanghai Henlius Biotech, Inc. Class H
HK$52.30
HK$28.42B
31.95
131.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$15.96
HK$23.88B
―
226.38%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$23.30
HK$37.22B
―
75.72%
0 Buy
2 Hold
0 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$10.44
HK$25.84B
33.01
87.10%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$76.35
HK$26.42B
―
173.17%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:2696
Shanghai Henlius Biotech, Inc. Class H
52.30
29.75
131.93%
DE:1ZLB
Zai Lab Ltd
2.90
1.36
88.31%
HK:9969
InnoCare Pharma Ltd.
15.96
11.07
226.38%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
23.30
10.04
75.72%
HK:2096
Simcere Pharmaceutical Group Limited
10.44
4.86
87.10%
HK:6855
Ascentage Pharma Group International
76.35
48.40
173.17%